Himmelfarb Health Sciences Library, The George Washington University

Health Sciences Research Commons
Microbiology, Immunology, and Tropical Medicine
Microbiology, Immunology, and Tropical Medicine
Faculty Publications
11-6-2014

Impact of gender on the decision to participate in a
clinical trial: a cross-sectional study
Lucas Lobato
Federal University of Minas Gerais

Jeffrey M. Bethony
George Washington University

Fernanda Bicalho Pereira
Federal University of Minas Gerais

Shannon Lee Grahek
Federal University of Minas Gerais

David J. Diemert
George Washington University
See next page for additional authors

Follow this and additional works at: https://hsrc.himmelfarb.gwu.edu/smhs_microbio_facpubs
Part of the Medical Immunology Commons, and the Medical Microbiology Commons
Recommended Citation
Lobato, L., Bethony, J.M., Pereira, F.B., Grahek, S.L., Diemert, D. et al. (2014). Impact of gender on the decision to participate in a
clinical trial: a cross-sectional study. BMC Public Health, 4:1156.

This Journal Article is brought to you for free and open access by the Microbiology, Immunology, and Tropical Medicine at Health Sciences Research
Commons. It has been accepted for inclusion in Microbiology, Immunology, and Tropical Medicine Faculty Publications by an authorized
administrator of Health Sciences Research Commons. For more information, please contact hsrc@gwu.edu.

Authors

Lucas Lobato, Jeffrey M. Bethony, Fernanda Bicalho Pereira, Shannon Lee Grahek, David J. Diemert, and
Maria Flavia Gazzinelli

This journal article is available at Health Sciences Research Commons: https://hsrc.himmelfarb.gwu.edu/smhs_microbio_facpubs/
155

Lobato et al. BMC Public Health 2014, 14:1156
http://www.biomedcentral.com/1471-2458/14/1156

RESEARCH ARTICLE

Open Access

Impact of gender on the decision to participate in
a clinical trial: a cross-sectional study
Lucas Lobato1*, Jeffrey Michael Bethony2, Fernanda Bicalho Pereira1, Shannon Lee Grahek2, David Diemert2
and Maria Flávia Gazzinelli1

Abstract
Background: In order for Informed Consent to be ethical and valid each clinical trial participant must be able to
make a voluntary decision to participate, free from pressure or coercion. Nonetheless, many factors may influence
the decision reached, and such influences may be different for male and female volunteers. Being aware of these
differences may help researches develop better processes for obtaining consent that safeguard the right of
autonomy for all participants. The goal of this study was to evaluate potential gender-based differences in the
factors influencing clinical trial participation.
Methods: This cross-sectional study was conducted in the Northeast region of Minas Gerais, Brazil, in October 2011.
A structured questionnaire was administered to 143 volunteers (48 male, 95 female) screened for participation in a
clinical study of an investigational functional food with potential anthelminthic properties. Answers regarding their
decision to participate in the study were compared, by gender, using chi-square and Mann Whitney tests. Odds
ratios (OR) was used to measure association.
Results: A majority of subjects (58% of males, 59% of females) listed the desire to collaborate with the development of
a product against parasitic worms as their main reason for participation. Females were significantly more likely
to report a decision influenced by friends, family, or researchers (OR 3.14, 3.45, and 3.46 respectively, p < 0.005).
Females were also significantly more likely to report a decision influenced by general altruistic considerations
(OR 8.45, p < 0.005). There was no difference, by gender, in the report of decisions influenced by informational
meetings, understanding of the disease, or the availability of medical treatments or exams. There was also no
difference in knowledge of the rights of research participants.
Conclusion: Study results indicate that there is a strong difference between male and female participants
regarding social influences on the decision to participate in clinical research. Further research into the impact
this may have on autonomy is warranted.
Keywords: Autonomy, Bioethics, Clinical research, Gender, Informed consent, Social influence, Voluntariness

Background
Obtaining the informed consent (IC) of potential clinical
trial participants is an essential element of ethical human
subjects research [1]. A critical component of the IC
process is to treat each research participant with dignity,
and to protect and promote his or her autonomy. In
Brazil, as in many other countries, IC is both an ethical
procedure and a legal requirement [2]. IC and the
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procedures for obtaining IC are captured in legal, philosophical, institutional, and medical literature as a set of key
elements – Information, Comprehension, Voluntariness,
Competence, and Decision. IC is valid only if obtained
through a process that ensures that all of the key elements
are addressed [3]. Of these elements, voluntariness in
particular has been of increasing interest to researchers.
Voluntariness is the right of potential participants to
make their own decisions, free from harassment or coercion that might lead them to act against their best interests [4]. Voluntariness may be impeded or empowered by
external influences, including the social influence of
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family, friends, and the community, as well as the level
of knowledge regarding participant rights, and access to
health services or medical treatments provided through
participation in a clinical trial that are not otherwise
available [5,6].
Additional research is needed to better understand the
external influences on taking voluntary decisions to
participate in clinical trials, as well as the groups that
are more or less likely to experience these influences,
and what steps may be taken in the informed consent
process to minimize coercive influences and maximize
autonomous decision making. Of particular concern in
some clinical trial settings are patriarchal family structures
that may result in gender-specific decision-making processes, with female participants under pressure to please
male family leaders [7,8].
The concept of gender encompasses the structure of
social relationships institutionalized in a society, as well
as individual relationships between males and females,
their commonly accepted roles in society, and their
everyday habits [9]. Therefore, a great deal of what is
understood as masculine and feminine – with accompanying roles, representations, and responsibilities – goes
through a construction process that is essentially social
[10,11]. Concepts of differential gender roles are imparted
and sustained through education and informal means
[12]. Socially constructed gender roles are often considered attributes of femininity and masculinity and upheld
in societies as natural or biological differences [13,14]. In
this context gender roles determine the social expectations
of each individual – what to think, how to act, what to
wear, and what the individual’s relationship to him or
herself and to someone else should be [9,15].
Based on this background, the hypothesis of this study
is that the decision to participate in a clinical trial may
differ by gender due to preexisting social influences on
the decision-making process. There are socio-behavioral
arguments, particularly relevant to clinical trials in Brazil,
which support this hypothesis. Historically, many families
in rural communities in Brazil have been structured with
significant gender inequality and male dominance over
the behavior of female family members [16,17]. Such
organization is molded after a patriarchal system that
governs all aspects of collective and individual activities,
and includes role differentiation and hierarchy between
sexes [18]. Therefore, the family structure revolves
around male supremacy, valuing male-dominated activities at the expense of female-dominated ones, and legitimizing male control over the female body, sexuality, and
autonomy [19].
Previous studies have examined the factors influencing
the decision of individuals in these communities to participate in clinical trials, as well as levels of knowledge
about the rights of research subjects [5,20]; however,
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these studies have not investigate whether the influencing factors affect male and female participants equally.
Therefore, we conducted a study of the quality of the IC
process for a clinical study of a novel functional food in
a rural region of Northeastern Minas Gerais, Brazil, in
the context potential gender differences. This study is of
importance due to a rapid increase in the number of
clinical trials being conducted in Brazil, as well as in other
developing countries with similar gender-differentiated social structures [21,22]. The majority of what is known in
Brazil on the topic of IC is in the context of hospitalbased clinical trials [23,24], and although voluntariness is
considered one of the key elements of obtaining an ethical
and valid IC, most IC studies focus on information
comprehension [25,26]. There is little Brazilian or international literature dedicated to studying the voluntariness
to participate in clinical trials, or that has investigated differences in the willingness to participate that are based on
gender differences and voluntariness [27-30]. Therefore,
the primary objective of this study was to determine if
external factors influenced the decision to participate
in clinical trials and whether these varied by gender. In
keeping with Brazilian Resolution 196/96 [2], this
study may also provide information to build practical
strategies to strengthen the autonomy of all research
participants.

Methods
Study design and population

Across-sectional, descriptive and quantitative questionnaire was administered to willing individuals who were
consented to participate in a clinical study entitled “A
Double-blind, Randomized, Controlled Evaluation of the
Tolerability of a Proprietary Oil Blend in Adults Residing
in Areas Endemic for Helminth Infections” (Clinicaltrials.
gov number NCT01271049), the primary objective of
which was to evaluate the tolerability of a functional
food with potential anthelminthic qualities among adults
residing in an area of Brazil endemic for intestinal helminth
infections. The clinical study took place in the district of
Novo Oriente de Minas in the northeastern region of
Minas Gerais, Brazil, between October 2011 and March
2012. Written informed consent was obtained from all
volunteers who were willing to be screened for participation in the study. The Informed Consent Form (ICF) was
read to each participant, or if the subject was literate, staff
and the participant read the ICF together. After obtaining
IC, participants were asked to complete a structured questionnaire to evaluate factors influencing their decision to
participate in the clinical study.
One hundred and sixty-nine volunteers were screened
for participation in the clinical study, and all agreed to
complete the questionnaire. Due to a delay between
obtaining consent and the administration of questionnaire
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(approximately one month), only 143 of 169 originally
consented participants completed the questionnaire substudy. The reasons cited for non-participation following
original consent were anticipated or actual change of residence to a different municipality (15) and the withdrawal
of consent (11).
Study approval was received from the ethical review
committees of the George Washington University, the
René Rachou Research Center, and the Federal University
of Minas Gerais.

scores ranging from 0 to 8. Higher scores indicated
greater influence by the evaluated factors and lower
values lower influence. At the extremes, a total score of
0 indicated that the participant was not influenced by
any factors evaluated in the questionnaire, whereas a
total score of 8 indicated that the participant was influenced by all factors evaluated. Differences in the General
Influence Index for male and female participants were
compared using the Mann–Whitney test. P values of less
than 5% were considered statistically significant.

Data collection and statistical analysis

Results
A total of 143 subjects completed the questionnaire, corresponding to 85% of the total number of volunteers who
were approached. Participants were 34 years old on average, with a majority self-reporting as black or of mixed
race. A majority of participants were also female, married,
illiterate or had less than an 8th grade education, had a
family income of over BRL 545 (USD 247), and accessed
electronic media more than five times per week. There
were no statistically significant differences in demographics or socioeconomic status by gender (Table 1) or
age (t-test; p =0.32).There was also no significant difference in the sub-study population and the community
from which volunteers were recruited in terms of age,
race, gender, marital status, formal schooling, monthly
income, and residence location (chi-square test and
Mann Whitnney test; p >0.05 for all statistical tests).
A majority of participants cited collaborating in the
development of a product against parasitic worms (i.e., the
aim of the clinical study) as a motivation for participating
in the clinical trial (58.0% and 59.5% for male and female
participants, respectively). The potential of overcoming
difficulties in accessing medical care was cited by 39.8% of
male participants and 35.7% of female participants as
being a motivating factor for study participation. A small
minority of subjects in both gender groups (2.9% and 5.3%
for males and females, respectively) indicated the desire to
please researchers as a reason to participate in the study
(Figure 1). Differences in factors motivating participation
between gender groups were not statistically significant
(chi-square; p =0.67).
In regard to the rights of study participants, both male
and female participants were most knowledgeable of the
right to withdraw from the clinical trial at any time.
Participants also displayed an understanding of the availability of medical treatment that was available outside of
participation in the clinical study (e.g., at the municipal
health clinic). Knowledge of these rights did not significantly differ by gender (p =0.46). Both genders showed
low knowledge of the right to continued medical treatment to which they are otherwise entitled in the case of
withdrawal of consent, with no significant difference by
gender (p =0.82) (Table 2).

Data for this sub-study were collected via a structured
questionnaire designed to evaluate the voluntariness of
the decision to participate in the clinical study and the
participants’ understanding of clinical research. In order
to assess voluntariness, the questionnaire addressed possible factors influencing the decision to participate in the
study, the primary reason for participating, and the level
of knowledge about the rights of research participants.
Questions were developed with guidance from other
questionnaires used for similar purposes [31,32], the
requirements of Resolution 196/96 of the National Health
Council of Brazil on human subjects research [2], and
international standards (such as the International Conference on Harmonisation). Questions were formatted
as dichotomous “yes” or “no” questions.
Questionnaires required 10 minutes on average for
completion, and were administered in an interview format in the residence of the participant. Interviewers
were trained to standardize the information collection
process in order to maximize reliability of the data and
minimize bias. Following collection the data were
coded and entered into an SPSS database (Version
14.0. Chicago, SPSS Inc.). Error was reduced through
independent double data entry. In the case of discrepancies, the data in question were confirmed by review of the
original questionnaire.
Data were described by absolute frequency, while quantitative variables were summarized by arithmetic means
and standard deviations. Differences in socioeconomic,
demographic, and motivation factors were compared by
gender using the chi-square test for categorical data and
the independent t-test for quantitative variables. Odds
ratios (OR) and associated 95% confidence intervals were
used to estimate associations, and the chi-square test used
to verify the significance of associations.
To analyze the combined influence of all factors on
the decision to participate in a clinical study an index
called the General Influence Index was created. Each
factor marked as influential to a participant’s decision
received a score of 1, and each factor marked as not influential received a score of 0. Eight factors of influence
were assessed for each participant, resulting in total
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Table 1 Socio-demographic and economic status (n =143)
Variable

Male

Female

- Elementary school

31 (21.7%)

64 (44.8%)

- High school

17 (11.8%)

31 (21.7%)

- Below R$545

22 (15.4%)

50 (34.9%)

- Above to R$545

26 (18.3%)

45 (31.4%)

- Single

11 (7.6%)

18 (12.6%)

- Married

37 (25.9%)

77 (53.9%)

- 2 to 4 times

17 (11.8%)

24 (16.7%)

- 5 to 7 times

31(21.8%)

71 (49.7%)

48 (27.7%)

95 (72.3%)

χ2

p

0.11

0.79

0.59

0.48

0.31

0.57

0.97

0.40

-

-

Education level

Family income

Marital status

Access to electronic media (per week)

Total

In the General Influence Index, female participants
scored an average of 6.2 (SD: 1.76) with a median of 7.0,
and male participants an average of 5.0 (SD: 1.97), median
of 5.0 (Z = −3.61. U =1449.5; p =0.02). Both gender groups
included participants with minimum scores of 0 (no influence) and maximum scores 8 (influenced by all factors
evaluated). Figure 2 shows a boxplot of the General Influence Index, by gender.
Female participants were significantly more likely than
male participants to report a decision influenced by
friends, family, the researcher and the altruism (OR: 3.14,
3.45, 3.46 and 8.45, respectively, p < 0.005 in statistical
tests), while no decision-influencing factors were significantly more likely among male participants (Table 3).

Discussion
The results of this study indicate that male and female
participants differed in the factors that influenced their
decision to participate in the ABS-00-02 clinical trial.

Most importantly, female participants were more likely
than male participants to have their decision to participate
influenced by their partner or their families. These results
support the theory that the decision to participate in clinical research may be impacted not only by the individual
characteristics of participants, but also by interpersonal relationships and social norms of the community where the
study is conducted [33]. A similar pattern was found in a
study conducted in Ghana, where all interviewed female
participants indicated that they consulted their husbands
before deciding to participate. Of these, some indicated
that if their husband had been against their participation
they would have declined, whereas others indicated that
the final decision was their own to make [34]. In another
study in Ghana, it was observed that the decision of female volunteers to participate was frequently subject to
the control of a parent or husband [35].
It is hypothesized that the influence of a partner or
family member is greater in clinical trials taking place in

Figure 1 The lines represents the percentage of responses of the reasons for participation in the clinical trial ABS-00-02.
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Table 2 Knowledge about the rights of the clinical trial participant ABS-00-02, according to the genre
Question

Male

Female
n (%)

χ2

p

OR

CI (95%)

Alternative of medical treatment

39 (81,1%)

71 (74,4%)

0,54

0,45

0,72

0,30 -1,71

Withdraw from the research

44 (91,6%)

86 (90,5%)

0,56

0,82

0,86

0,25 - 2,98

Maintenance of medical treatment in case of leaving the study

14 (29,1%)

22 (23,1%)

0,48

0,54

0,77

0,35- 1,69

Statistical test for Chi-Square; Odds Ratio; Confidence Interval (95%).
Americaninhas, Minas Gerais, 2011 (n =143).

developing countries than in developed countries. This
is supported by the results of a multicenter study of
hypertension and genetics, in which no female participants enrolled in the US solicited the advice of a partner
before participation, compared to 47% of female participants enrolled in Nigeria that solicited the advice of their
partner prior to participating in the trial [7]. Despite this,
social influencers have also been observed in studies based
in developed countries, including a health services study
conducted in the UK enrolling 32 pregnant women, of
which 9 delegated their decision to be tested for HIV to
another person, including a partner, close friend, or health
professional. Of these, 3 reported feeling pressure to
consent to the test against their wish, due to external
influence [35].
Taken together, these studies indicate that the need or
desire to solicit advice from domestic partners or other

family members as part of the decision making process
may be greater for female participants in developing
country settings, but is likely to be observed to varying
degrees across settings. Although undue pressure by a
partner or family member to participate or not participate
in clinical research is an impediment to autonomy, consultation in itself may not be an impediment, and may in
fact lead to greater contemplation and a more informed
decision. Additional research is needed to understand the
extent to which the differences in social influence seen in
this study relate to undue pressure or coercion, or a difference in personal preference to seek consultation with
others prior to reaching an independent decision.
Although low for both groups, another important
finding of this study was the difference, by gender, in
the reported influence of researchers on the decision to
participate. It is thought that in Americaninhas, the site

Figure 2 General Influences represents the sum of influences that the participants of indicated when choosing to participate in the
clinical trial (Eight types of influence evaluated by the study). The figure shows a comparison of the general Influence according to the sex
of trial participants.
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Table 3 Influential factors in the decision of trial participants ABS-00-02 according to gender
Variables

Female

Male

Influenced

43 (45,3%)

10 (20,8%)

Not influenced

52 (54,7%)

38 (79,2%)

Influenced

58 (61,1%)

15 (26,7%)

Not influenced

37 (38,9%)

33 (73,3%)

χ2

p

OR

IC (95%)

8,15

0, 006

3,14

1,45 – 7,03

11,33

0, 001

3,44

1,65-7,20

8,67

0, 001

3,45

1,47 – 8,11

1,79

0,18

1,70

0,78 – 3,70

0,86

0,35

1,45

0,65 – 3,19

15,92

0,01

8,45

2,58 – 27,67

0,03

0,82

0,91

0,34 – 2,40

1,09

0,29

1,68

0,06 – 4,60

-

-

-

-

Friends

Family (Spouse)

Researcher
Influenced

83 (91,7%)

32 (66,7%)

Not influenced

12 (8,3%)

16 (33,3%)

Influenced

75 (78,9%)

33 (68,8%)

Not influenced

20 (21,1%)

15 (31,2%)

Influenced

74 (85,4%)

34 (70,9%)

Not influenced

21 (14,6%)

14 (29,1%)

Influenced

91(95,7%)

35 (72,9%)

Not influenced

4 (4,3%)

13 (27,1%)

Influenced

80 (84,3%)

41(85,5%)

Not influenced

15 (15,7%)

7 (14,5%)

Influenced

85 (89,4%)

40 (83,4%)

Not influenced

10(10,6%)

8 (16,6%)

Total

95 (72,3%)

48 (27,7%)

Meetings

Learning about the disease

Helping others (altruism)

Medical treatment

Medical exams

Statistical test for Chi-Square; Odds Ratio; Confidence Interval (95%).
Americaninhas, Minas Gerais, 2011 (n =143).

of the ABS-00-02 study, this researcher influence is
comparable to the influence of health professionals on
patient decisions in hospital environments. This interpretation is supported by studies conducted in the same
region, which found that participants considered study
researchers as equivalent to standard care medical doctors [5,31]. A number of studies have also indicated that
in certain settings male health-seeking behavior may be
lower as compared to female health-seeking behavior
for a number of reasons, including a perceived weakness
or vulnerability in requiring medical assistance [36,37].
The non-differentiation of researchers from standard
care doctors combined with differing health-seeking
behaviors may therefore explain the difference in the
influence of researchers, by gender, on the decision to
participate in the ABS-00-02 clinical trial.
This study also examined motivating factors for voluntary participation, and may provide insight into the
question raised by Diniz [37] in an bioethics related
article, where he asked “…what would cause someone

to voluntarily put themselves at risk when there are no
financial advantages?” This question is especially pertinent
in countries such as Brazil, where offering financial incentives for participation in clinical research is prohibited [2].
Diniz cites a lack of access to medical treatment as the answer to this question, while our response is that there may
be many motivating factors in addition to, or in place of,
financial incentives. In this study, a high percentage of
ABS-00-02 participants did indicate that access to health
services was a motivating factor for participation, and lack
of access to medical treatment is commonly cited across
a number of settings, including in studies conducted in
African in response to the HIV/AIDS epidemic [38]. Alternative answers relating to the idea of voluntariness
are for the benefit to ones own family or community,
and for the benefit to society at large (general altruism).
In this study, the desire to collaborate in the development
of a product capable of fighting hookworm disease, highly
endemic in the region, was cited as a motivating factor for
participation in the ABS-00-02 trial by a majority of
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participants, both male and female. In another clinical
trial conducted in Brazil, and in trials conducted in
African, the Caribbean, the US, and Australia, general
altruism was reported as a major motivating factor for
participation [5,39,40].That said, for the ABS-00-02
study, only a small minor of participants reported general altruism as a motivating factor in their decision to
participate in the trial.
Although cited as a challenge to IC in developing
countries, nearly all participants in this study understood
the right to withdraw from the study at any time. Unfortunately, a lack of knowledge regarding alternatives to
participation may compel subjects to continue in studies
despite knowledge of the right of withdraw [41,42].
Therefore, knowledge regarding the right to withdraw
from research must be linked with an understanding of
alternatives to participation, including the right to not
participate without loss of medical treatment or care to
which one is otherwise entitled [38,43,44]. In this study
a majority of participants correctly cited the availability
of alternative medical treatments. Awareness of medical
alternatives may be due in part to the fact that residents
of Americaninhas have easy access to parasitological
exams and chemotherapy treatment in the Unidade Básica
de Saúde (Basic Health Unit), offered by the Sistema
Único de Saúde (Unified Public Health System) free of
charge, as well as access to additional exams and anthelmintic chemotherapy through the primary care network
of the Novo Oriente de Minas municipality. Given this, it
is not known if the observed high rate of understanding of
alternatives to participation would carry-over to another
trial for an indication not well understood by this study
population, or not addressed in the local health system.
This is in fact an area of great ethical debate. In a study in
Ghana a majority of participants cited participation as the
only method to obtain a medication for the treatment of
HIV/AIDS, and in some cases mistook research with medical treatment. This confusion may stem from the fact that
a number of studies conducted in the study area included
access to basic medical care not otherwise readily accessible to the population [42].
A possible limitation of this study is non-differential
recall bias due to the 1-month lag between volunteers
making a decision to participate in the clinical trial
and administration of the sub-study questionnaire.
Intentional responder bias is also possible if volunteers perceived a particular response to be more desirable. The potential for these biases was minimized by
a relatively short 1-month lag time between clinical
trial consent and questionnaire administration, the use
of simple closed-end questions, administration of the
questionnaire in a standardized fashion by trained interviewers, and exclusion of highly sensitive or culturally
taboo topics.
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Conclusion
In certain settings female participants appear to be more
likely than male participants to solicit the advice of domestic partners or family members prior to providing
consent to participate in clinical trials. Even where the
informed consent process meets national and international standards if such consultation includes undue
pressure the right to autonomy will be impacted [45,46].
Given this, some have asserted that in settings of
ingrained gender inequality, where such undue pressure
or coercion is likely, female study participants should in
fact be considered extrinsically vulnerable [47,48]. We
believe that acknowledgment and examination of differences in social influence on the decision-making process
is an important step to improving informed consent
processes and obtaining valid IC [49,50]. In settings where
autonomy may otherwise be compromised additional
strategies to promote IC should be considered, such as
educational interventions prior to study recruitment
[5,20,24]. However, in all settings such efforts should
not extend to exclusion of females from research studies
[38]. Not only would such exclusion negatively impact
the study of exclusively female conditions, it would deprive women of the many potential benefits of research
participation [51,52].
Additional evaluation of gender differences on the
decision to voluntarily participate in clinical research
is thus warranted, particularly to examine the degree
to which differences in social influence relate to undue
control over or decreased autonomy of female participants
versus individual preference for external consultation or
decision-making support. Additional research to assess
the perception of voluntariness using validated instruments such as the Decision Making Control Instrument is
also encouraged [53].
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